Noor Ul Ain Rehman
1 min read
In This Article:
Insmed Incorporated (NASDAQ:INSM) is one of the 10 Hot Large Cap Stocks to Buy Now. Tiago Fauth, an analyst from Wells Fargo, maintained a Buy rating on Insmed Incorporated (NASDAQ:INSM) on June 11, raising the associated price target to $119 from $107. The analyst based the positive rating on the promising developments in the company’s TPIP program, with Phase 2 results showing a notable decrease in pulmonary vascular resistance (PVR).
The results exceeded expectations and reflected the potential to become a leading inhaled prostacyclin therapy. The therapy also has ease of dosing, making it a differentiated option in the treatment of pulmonary arterial hypertension (PAH).
A biopharmaceutical research team taking notes in front of a laboratory's microscope.
The analyst further noted that TPIP has a positive safety profile, particularly in relation to cough rates. This positions it favorably compared to existing treatments, solidifying its market potential and supporting the optimistic outlook.
While we acknowledge the potential of INSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
